Est. 2015 · United Kingdom · USA · Austria
InauguralInvitation Only

Cell Therapy & Autoimmunity

USFocus Meeting 2027
Two days, 52 people, one room.
March 12 to 13, 2027
Chicago, IL
Support Opportunities →
Dates
March 12-13, 2027
Two-day program
Venue
Chicago, IL
Hotel TBC
Audience
52 by invitation
26 KOLs & 26 fellows
Format
8 sessions · 26 talks
Plenary, panels + keynotes

A Curated Room: The People Shaping Practice

This inaugural, invitation-only meeting convenes a deliberately small faculty: 26 leading cell therapy, rheumatology and neurology KOLs alongside 26 hand-selected fellows and junior faculty, the clinicians running the first autoimmune CAR T trials and the ones who will run the pivotal programs, in one room for two days.

The science tracks where treatment is moving: deep B-cell depletion and durable immune reset, trial readouts across SLE, SSc, myositis, gMG and SPS, safety and lymphodepletion in non-malignant patients, and next-generation platforms from CAR-Tregs to in vivo delivery. Every session pairs expert talks with a moderated panel, sustained, close-quarters engagement rather than a lecture hall.

Deep B-Cell DepletionLymphodepletion & ConditioningCAR-Tregs & ToleranceIn Vivo CAR-T & LNP DeliveryAllogeneic & Rapid ManufacturingSLE · SSc · Myositis · gMG · SPS
Meeting Co-Chairs
Listed alphabetically by surname
Michael-Bishop
Michael Bishop
The University of Chicago Medicine, Chicago, IL
David-Porter
David Porter
Penn Medicine, Philadelphia, PA
Ran-Reshef
Ran Reshef
Columbia University, New York, NY
Faculty Drawn From
University of Chicago · Penn · Columbia · Memorial Sloan Kettering · Massachusetts General and other leading US academic centers
52
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
21
Established meetings across the US and Europe, a proven platform
Cell Therapy & Autoimmunity US Focus Meeting 2027

Confirmed Faculty

Listed alphabetically by surname
Rohit Aggarwal
University of Pittsburgh, Pittsburgh, PA
Michael Bishop
The University of Chicago Medicine, Chicago, IL
Claudio Brunstein
Cleveland Clinic, Cleveland, OH
Joseph Fraietta
University of Pennsylvania, Philadelphia, PA
Alfred Garfall
University of Pennsylvania, Philadelphia, PA
Marcela Maus
Massachusetts General Hospital, Boston, MA
Aimee Payne
Columbia University, New York, NY
Miguel Perales
Memorial Sloan Kettering, New York, NY
David Porter
University of Pennsylvania, Philadelphia, PA
Ran Reshef
Columbia University, New York, NY
Katy Rezvani
MD Anderson Cancer Center, Houston, TX
Marco Ruella
University of Pennsylvania, Philadelphia, PA
Nirali Shah
University of Maryland School of Medicine, Baltimore, MD
Saira Sheikh
University of North Carolina, Chapel Hill, NC
Iazsmin Ventura
University of Chicago, Chicago, IL
Sarah Wesley
Columbia University, New York, NY
Anastasia Zekeridou
Mayo Clinic, Rochester, MN
Further faculty to be announced
Two Days, Eight Sessions

Proposed Agenda

Presentations15 min
Panel Discussions30 min
Lunch Break & Networking50 min
Day One · Friday, March 12, 2027
Session IBiological Rationale & Mechanisms of Immune Reset
Moderator
Historical Perspective: CAR-T Cells for Malignancy
David PorterUniversity of Pennsylvania, Philadelphia, PA
Deep B-Cell Depletion vs. Chronic Biologics: The Biology of “Immune Reset”
Speaker TBC
B-Cell Repopulation Dynamics After CAR-T
Michael BishopThe University of Chicago Medicine, Chicago, IL
Panel Discussion & Q&A
Session IICross-Disciplinary Landscape: Disease Primers & Clinical Operations
Moderator
Rheumatology Primer for Cell Therapists: SLE Disease Activity, Flares & Target Populations, Trial Design and Endpoints
Speaker TBC
Neurology Primer for Cell Therapists: CNS Compartmentalization & Autoantibody Targets Focus on MS/SPS
Sarah WesleyColumbia University, New York, NY
Panel Discussion & Q&A
Lunch Break & Networking
Session IIIClinical Trial Evidence in Systemic Rheumatic Diseases
Moderator
Systemic Lupus Erythematosus (SLE): Clinical Proof-of-Concept, Seroconversion & Remission Durability
Saira SheikhUniversity of North Carolina, Chapel Hill, NC
Systemic Sclerosis (SSc): Reversing Fibrosis and Modifying Microvascular Pathology
Iazsmin VenturaUniversity of Chicago, Chicago, IL
Idiopathic Inflammatory Myopathies (Myositis) & Overlap Syndromes: Trial Readouts
Rohit AggarwalUniversity of Pittsburgh, Pittsburgh, PA
Panel Discussion & Q&A
Session IVClinical Trial Evidence in Autoimmune Neurology
Moderator
Generalized Myasthenia Gravis (gMG): B-Cell Clearance, MG-ADL Dynamics & Trial Designs
Speaker TBC
Stiff Person Syndrome (SPS) & GAD65-Mediated Neurological Disorders
Anastasia ZekeridouMayo Clinic, Rochester, MN
Neurology Primer for Cell Therapists: Peripheral Nervous System and Neuromuscular Junction. Focus on CIDP/MG
Speaker TBC
Panel Discussion & Day 1 Synthesis
KeynoteWhat Does the Future Hold for Cell Therapy (Tentative)
Speaker TBC
Partnership Opportunities Now Open

Bespoke engagement packages for a closed, invitation-only audience

Request the Prospectus →
Tania Lifanova
Your Point of Contact
Tania Lifanova
Account Executive, MD Education